Compounds > voriconazole
Page last updated: 2024-08-25

voriconazole and Pneumonia, Bacterial

voriconazole has been researched along with Pneumonia, Bacterial in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (50.00)29.6817
2010's1 (25.00)24.3611
2020's1 (25.00)2.80

Authors

AuthorsStudies
Gao, W; Lu, H; Wang, H; Wu, G; Yang, C; Yuan, C1
Hori, D; Kishimoto, K; Kobayashi, K; Kobayashi, R; Sano, H; Suzuki, D; Yasuda, K1
Gottfredsson, M; Steingrímsdóttir, H1
Hasegawa, Y; Hitomi, S; Imagawa, S; Ishii, Y; Kaneko, S; Kojima, H; Machino, T; Mukai, HY; Muto, H; Nagasawa, T; Okoshi, Y; Suzukawa, K1

Other Studies

4 other study(ies) available for voriconazole and Pneumonia, Bacterial

ArticleYear
Case report: Mycobacterium monacense isolated from the blood culture of a patient with pulmonary infection.
    BMC infectious diseases, 2020, Mar-12, Volume: 20, Issue:1

    Topics: Adult; Blood Culture; Cefoperazone; China; DNA, Ribosomal; Humans; Linezolid; Male; Mycobacterium; Mycobacterium Infections, Nontuberculous; Pneumonia, Bacterial; Sulbactam; Voriconazole

2020
Prophylactic administration of voriconazole with two different doses for invasive fungal infection in children and adolescents with acute myeloid leukemia.
    Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi, 2018, Volume: 51, Issue:2

    Topics: Adolescent; Adult; Anti-Bacterial Agents; Antifungal Agents; Child; Child, Preschool; Drug Monitoring; Female; Humans; Infant; Infant, Newborn; Invasive Fungal Infections; Japan; Leukemia, Myeloid, Acute; Male; Neutropenia; Pneumonia, Bacterial; Pre-Exposure Prophylaxis; Retrospective Studies; Treatment Outcome; Trimethoprim, Sulfamethoxazole Drug Combination; Voriconazole; Young Adult

2018
Disseminated invasive aspergillosis in a patient with acute leukaemia.
    Acta bio-medica : Atenei Parmensis, 2006, Volume: 77 Suppl 2

    Topics: Acute Kidney Injury; Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Aspergillosis; Bacteremia; Caspofungin; Chlamydophila Infections; Chlamydophila pneumoniae; Doxorubicin; Drug Resistance, Multiple, Fungal; Drug Therapy, Combination; Echinocandins; Fatal Outcome; Female; Humans; Immunocompromised Host; Lipopeptides; Liposomes; Lung Diseases, Fungal; Medical Futility; Methotrexate; Middle Aged; Neuroaspergillosis; Peptides, Cyclic; Pneumonia, Bacterial; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Streptococcal Infections; Triazoles; Vincristine; Voriconazole

2006
Quinupristin/dalfopristin and voriconazole controlled Staphylococcus epidermidis pneumonia and chronic necrotizing aspergillosis in a patient with severe lung degradation consequent to multiple treatments for Hodgkin's lymphoma.
    Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2006, Volume: 12, Issue:6

    Topics: Adult; Anti-Bacterial Agents; Antifungal Agents; Aspergillosis; Aspergillus niger; Chronic Disease; Drug Therapy, Combination; Female; Hodgkin Disease; Humans; Lung Diseases, Fungal; Lymphatic Irradiation; Necrosis; Pneumonia, Bacterial; Pyrimidines; Radiation Injuries; Radiography; Staphylococcal Infections; Staphylococcus epidermidis; Triazoles; Virginiamycin; Voriconazole

2006